A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab
Sign Up to like & getrecommendations! Published in 2022 at "Advances in Therapy"
DOI: 10.1007/s12325-022-02042-3
Abstract: Since the beginning of the pandemic, numerous national and international clinical trials have been conducted with a large number of drugs. Many of them are intended for the treatment of other pathologies; however, despite the… read more here.
Keywords: antagonists siltuximab; covid; new approach; management covid ... See more keywords